Picture of Alliance Pharma logo

APH Alliance Pharma News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

REG - Alliance Pharma PLC Logistics Dev Grp - Notification of Major Holdings

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230130:nRSd3132Oa&default-theme=true

RNS Number : 3132O  Alliance Pharma PLC  30 January 2023

TR-1: Standard form for notification of major holdings

 

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible)

 1a. Identity of the issuer or the underlying issuer of existing shares to                                                                                    Alliance Pharma Plc
 which voting rights are attached :
 1b. Please indicate if the issuer is a non-UK issuer  (please mark with an
 "X" if appropriate)
 Non-UK issuer
 2. Reason for the notification (please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights                                                                                                                                                                                                            X
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights
 Other (please specify) :
 3. Details of person subject to the notification obligation
 Name                                                                                                                                                         DBAY Advisors Limited as discretionary investment manager of Fixtaia Limited,
                                                                                                                                                              Logistics Development Group Plc and DouglasBay Capital IV Fund LP
 City and country of registered office (if applicable)
 4. Full name of shareholder(s) (if different from 3.)
 Name                                                                                                                                                         Pershing Nominees Limited
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reached :                                                                                                      27 January 2023
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                                               30 January 2023
 7. Total positions of person(s) subject to the notification obligation
                                                                            % of voting rights attached to shares (total of 8. A)  % of voting rights through financial instruments      Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer (8.A + 8.B)

(total of 8.B 1 + 8.B 2)
 Resulting situation on the date on which threshold was crossed or reached                                                                                                               8.03%                           43,342,916

                                                                            8.03%
 Position of previous notification (if                                      7.97%                                                                                                        7.97%

 applicable)

 

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reached
 A: Voting rights attached to shares
 Class/type of                                  Number of voting rights                                              % of voting rights

shares

 ISIN code (if possible)
                                                Direct                  Indirect                                     Direct                                           Indirect

                                                (DTR5.1)                 (DTR5.2.1)                                  (DTR5.1)                                         (DTR5.2.1)
 GB0031030819                                                           43,342,916                                                                                    8.03%

 SUBTOTAL 8. A                                  43,342,916                                                           8.03%

 B 1: Financial Instruments according to DTR5.3.1R (1) (a)
 Type of financial instrument                   Expiration  Exercise/                        Number of voting rights that may be acquired if the instrument is        % of voting rights

date
Conversion Period

                                                                                             exercised/converted.

                                                            SUBTOTAL 8. B 1

 B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
 (1) (b)
 Type of financial instrument  Expiration                   Exercise/               Physical or cash                                         Number of voting rights  % of voting rights

date
Conversion Period

                                                                                    Settlement

                                                                                    SUBTOTAL 8.B.2

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the

 applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuer
 Full chain of controlled undertakings through which the voting rights and/or                                                                                                                                                  X
 the

financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entity (please add additional rows as
 necessary)
 Name                             % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                              than the notifiable threshold
 DBAY Advisors Limited            8.03%                                                                                                                                                   8.03%
 Logistics Development Group Plc  3.34%                                                                                                                                                   3.34%
 Fixtaia Limited                  3.34%                                                                                                                                                   3.34%
 DouglasBay Capital IV Fund LP    4.69%                                                                                                                                                   4.69%

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 11. Additional information

 

 Place of completion  DOUGLAS, ISLE OF MAN
 Date of completion   30 January 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLEAXFEDFSDEFA

Recent news on Alliance Pharma

See all news